Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel application of minor radix buplenri granules combined chloroquine phosphate tablets

A technology of Xiao Chai Hu granules and chloroquine phosphate, which can be applied to medical preparations, drug combinations, plant raw materials and other directions containing active ingredients, and can solve the problems of accelerated clinical symptoms improvement, inferior virus clearance, and insignificant curative effect.

Active Publication Date: 2020-06-26
GUANGZHOU BAIYUSN GUANGHUA PHARMA
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The latest clinical research shows that lopinavir, ritonavir (Kaletra) and Arbidol for the treatment of novel coronavirus pneumonia are not superior to the control group in terms of improving clinical symptoms and accelerating virus clearance, and the curative effect is not significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel application of minor radix buplenri granules combined chloroquine phosphate tablets
  • Novel application of minor radix buplenri granules combined chloroquine phosphate tablets
  • Novel application of minor radix buplenri granules combined chloroquine phosphate tablets

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] The present invention finds that the minimum inhibitory concentration of Xiaochaihu granules to the standard strain of Mycoplasma pneumoniae FH is 3.125 mg / mL through the in vitro antibacterial test of the standard strain of Mycoplasma pneumoniae, and the minimum inhibitory concentration of chloroquine phosphate tablets to the standard strain of Mycoplasma pneumoniae FH is 8 mg / mL. mL, Xiaochaihu granules combined with azithromycin can significantly reduce the minimum inhibitory concentration of azithromycin (0.002mg / ML→0.0005mg / mL), and Xiaochaihu granules+chloroquine phosphate tablets combined with azithromycin can significantly reduce the minimum inhibitory concentration of azithromycin (0.002mg / ML→0.0005mg / mL). ML→0.000125mg / mL), indicating that Xiaochaihu granules, Xiaochaihu granules combined with azithromycin, Xiaochaihu granules + chloroquine phosphate tablets combined with azithromycin can significantly inhibit Mycoplasma pneumoniae in vitro, that is, it is found...

Embodiment 2

[0057] The present invention uses the SD rat model infected by Mycoplasma pneumoniae to conduct experiments, and finds that Xiaochaihu granules, especially Xiaochaihu granules combined with chloroquine phosphate tablets can significantly increase glutathione peroxidase, superoxide dismutase, peroxidase The level of hydrogenase can reduce the content of malondialdehyde, and its effect is stronger than that of Xiaochaihu granules and chloroquine phosphate alone, indicating that the combined administration can improve the body's ability to scavenge free radicals and reduce the cytotoxicity caused by free radical accumulation, that is, the discovery of Xiaochaihu granules Combined with chloroquine phosphate tablets, it has the purpose of eliminating excessive free radicals caused by Mycoplasma pneumoniae infection.

[0058] The use of Xiaochaihu Granules combined with Chloroquine Phosphate Tablets for removing excess free radicals caused by Mycoplasma pneumoniae infection is furthe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

According to the invention, an SD rat model infected by mycoplasma pneumoniae is adopted for experiments, and it is found that minor radix buplenri granules can remove excessive free radicals caused by mycoplasma pneumoniae infection. In particular, through combination of the minor radix buplenri granules and chloroquine phosphate, the levels of glutathione peroxidase, superoxide dismutase and catalase in serum can be obviously increased, and the content of malondialdehyde can be reduced, so that combined administration can improve the free radical removing capability of an organism and reducecytotoxicity generated by free radical accumulation. The minor radix buplenri granules combined chloroquine phosphate tablets have a purpose of removing excessive free radicals caused by mycoplasma pneumoniae infection, solve the problem of excessive free radicals in mycoplasma pneumoniae infection, have a better sensitization effect on azithromycin, and thus can be used for preventing and treating mycoplasma pneumoniae.

Description

technical field [0001] The invention relates to a new application of Xiaobupleurum granules combined with chloroquine phosphate, and belongs to the field of combined Chinese and Western medicines. Background technique [0002] Mycoplasma pneumoniae is the pathogen of primary atypical pneumonia in humans and one of the most common pathogens of community-acquired pneumonia in my country. Mycoplasma pneumoniae infection is mainly transmitted through droplets, which can cause upper and lower respiratory diseases such as pharyngitis, bronchitis, and acute pneumonia, and can also cause complications such as encephalitis, radiculitis, myocarditis, and hemolytic anemia. Macrolide antibiotics are the first choice for its treatment. However, studies have shown that the in vitro resistance rate of Mycoplasma pneumoniae in my country to macrolide antibiotics is significantly higher than that in other countries. Therefore, we should be vigilant and try other drug combinations. The lates...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61K31/4706A61P11/00A61P31/04A61P39/06
CPCA61K36/233A61K36/539A61K36/8888A61K36/344A61K36/9068A61K36/484A61K36/725A61K31/4706A61P11/00A61P31/04A61P39/06A61K2300/00
Inventor 刘宏张俊华毕聪郑如文江志强何逸禧杜海泳
Owner GUANGZHOU BAIYUSN GUANGHUA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com